MedPath
NMPA Approval

Levodropropizine Oral Solution

国药准字H20254461

June 3, 2025

Drug Information

左羟丙哌嗪口服溶液

口服溶液剂

10ml:60mg

化学药品

June 3, 2025

Company Information

Applicant Company

安徽省合肥市高新区望江西路6589号1幢义齿加工生产综合楼201室

Manufacturing Company

合肥市庐阳产业园下塘路杏花分园8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.